Matches in Wikidata for { <http://www.wikidata.org/entity/Q91168777> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q91168777 description "article scientifique publié en 2019" @default.
- Q91168777 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91168777 description "scientific article published on 22 January 2019" @default.
- Q91168777 description "wetenschappelijk artikel" @default.
- Q91168777 description "наукова стаття, опублікована 22 січня 2019" @default.
- Q91168777 name "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 name "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 type Item @default.
- Q91168777 label "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 label "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 prefLabel "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 prefLabel "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 P1433 Q91168777-E4907259-903E-4AEE-990C-51362894932A @default.
- Q91168777 P1476 Q91168777-9EE18572-CA77-457C-9C5A-7D5931CAF489 @default.
- Q91168777 P2093 Q91168777-054B8ECD-709D-4846-9A9C-DEFE5F19515C @default.
- Q91168777 P2093 Q91168777-2FD1356B-5781-40E0-9476-D83CC9AF8C21 @default.
- Q91168777 P2093 Q91168777-4B55424B-81C2-4942-BFA4-4F699C209416 @default.
- Q91168777 P2093 Q91168777-60BAE51C-1D82-4CEE-B194-EF685FBCA5EB @default.
- Q91168777 P2093 Q91168777-8DA4EAA8-F53D-422D-A324-58F6FCB274C5 @default.
- Q91168777 P2093 Q91168777-A62B8895-96C9-4B12-A813-E299F5B3004E @default.
- Q91168777 P2093 Q91168777-ACE35923-9B52-41AD-A587-257DD8023254 @default.
- Q91168777 P2093 Q91168777-D0861B7F-A4A3-437F-B4C1-4DA3E2F9EA7A @default.
- Q91168777 P2093 Q91168777-FBE160D3-FDCC-40CD-A9C2-52D6F23AEAF6 @default.
- Q91168777 P2860 Q91168777-085A6B86-F99D-4BEB-88B8-AEC6F3031F56 @default.
- Q91168777 P2860 Q91168777-0CBB0DE5-75DE-4F0F-865E-9A1DE26626C0 @default.
- Q91168777 P2860 Q91168777-0DDFC14A-20F9-4F46-8E4D-2385A433A3B9 @default.
- Q91168777 P2860 Q91168777-682481D6-DE41-4757-8194-AA3A456733E1 @default.
- Q91168777 P2860 Q91168777-6D250F6A-6944-4C37-B59C-4F5FA021461F @default.
- Q91168777 P2860 Q91168777-75686936-2C6A-4C1B-9E48-FC801FF981DB @default.
- Q91168777 P2860 Q91168777-93EBC8E6-436B-4F0E-93BA-EEE795919E12 @default.
- Q91168777 P2860 Q91168777-9F1253B7-4987-4D8E-8887-88C6FC17F173 @default.
- Q91168777 P2860 Q91168777-ACF29EBE-B9B2-417A-A7A9-53596840F2A4 @default.
- Q91168777 P2860 Q91168777-BE664BE3-9F84-40EF-83E6-262BD86BA143 @default.
- Q91168777 P2860 Q91168777-CB666D1C-10E1-46D9-842E-E87B3B87798E @default.
- Q91168777 P2860 Q91168777-DF74A61D-727A-4128-BD5A-F8423204DC87 @default.
- Q91168777 P304 Q91168777-EAA2AE48-46AA-4272-B809-AEED393746FA @default.
- Q91168777 P31 Q91168777-DB4B89FC-DCAC-41D1-B0FC-4EE805D19BC0 @default.
- Q91168777 P356 Q91168777-0B009F19-6C03-47AA-B336-1C900D9C9735 @default.
- Q91168777 P433 Q91168777-9FCFAF28-A191-40EB-8975-8B27766D8A82 @default.
- Q91168777 P478 Q91168777-4FAF4856-B702-4E1D-A4C7-498E84ABF8C4 @default.
- Q91168777 P50 Q91168777-9DDF137C-0A9B-4013-B5F3-6C6B8A8CC699 @default.
- Q91168777 P50 Q91168777-D7059A0F-E7FD-4E9D-A694-27FE41EBD649 @default.
- Q91168777 P577 Q91168777-5CACF133-F328-4405-B865-DF7253B5CDB5 @default.
- Q91168777 P698 Q91168777-DF3EBAAB-4A9E-4B03-B20D-1B36AD5260E2 @default.
- Q91168777 P356 S41409-019-0436-1 @default.
- Q91168777 P698 30670826 @default.
- Q91168777 P1433 Q4941523 @default.
- Q91168777 P1476 "Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement" @default.
- Q91168777 P2093 "Chiaki Kobayashi" @default.
- Q91168777 P2093 "Daigo Akahane" @default.
- Q91168777 P2093 "Hiroaki Fujimoto" @default.
- Q91168777 P2093 "Junko H Ohyashiki" @default.
- Q91168777 P2093 "Kazuma Ohyashiki" @default.
- Q91168777 P2093 "Kenko Azuma" @default.
- Q91168777 P2093 "Nahoko Furuya" @default.
- Q91168777 P2093 "Naoya Nakamura" @default.
- Q91168777 P2093 "Tamiko Suguro" @default.
- Q91168777 P2860 Q27853375 @default.
- Q91168777 P2860 Q28258633 @default.
- Q91168777 P2860 Q34548116 @default.
- Q91168777 P2860 Q35085226 @default.
- Q91168777 P2860 Q37724934 @default.
- Q91168777 P2860 Q38314950 @default.
- Q91168777 P2860 Q47849783 @default.
- Q91168777 P2860 Q52730056 @default.
- Q91168777 P2860 Q58455690 @default.
- Q91168777 P2860 Q64008518 @default.
- Q91168777 P2860 Q84596449 @default.
- Q91168777 P2860 Q90826216 @default.
- Q91168777 P304 "1148-1150" @default.
- Q91168777 P31 Q13442814 @default.
- Q91168777 P356 "10.1038/S41409-019-0436-1" @default.
- Q91168777 P433 "7" @default.
- Q91168777 P478 "54" @default.
- Q91168777 P50 Q59707129 @default.
- Q91168777 P50 Q64025696 @default.
- Q91168777 P577 "2019-01-22T00:00:00Z" @default.
- Q91168777 P698 "30670826" @default.